Biomanufacturing of human mesenchymal stem cells in cell therapy: Influence of microenvironment on scalable expansion in bioreactors

Biochemical Engineering Journal

Volumn 108, Issue , 2016, Pages 44-50

  Ma, Teng ^a   Tsai, Ang Chen ^a   Liu, Yijun ^a  

^a FAMU FSU COLLEGE OF ENGINEERING   (United States)

Author keywords

Bioreactors; Human mesenchymal stem cell (hMSC); Large scale cultivation; Microcarriers; Microenvironment; Tissue cell culture

Indexed keywords

BIOCONVERSION; BIOREACTORS; CELL CULTURE; CELLS; CYTOLOGY; DISEASE CONTROL; EXPANSION; TISSUE CULTURE;

CLINICAL TRANSLATION; CULTURE CONDITIONS; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); LARGE SCALE CULTIVATIONS; MICROCARRIERS; MICROENVIRONMENTS; SCALABLE EXPANSION;

STEM CELLS;

BIOMANUFACTURING; BIOREACTOR; BIOTECHNOLOGICAL PROCEDURES; CELL EXPANSION; CELL FATE; CELL THERAPY; CLONOGENESIS; HUMAN; MESENCHYMAL STEM CELL; NOTE; PRIORITY JOURNAL;

EID: 84959373443     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2015.07.014     Document Type: Note

References (64)

1. Heathman T.R., Nienow A.W., McCall M.J., Coopman K., Kara B., Hewitt C.J. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen. Med. 2015, 10:49-64.
2. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 1994, 331:889-895.
3. Bara J.J., Richards R.G., Alini M., Stoddart M.J. Concise review: bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells 2014, 32:1713-1723.
4. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324:1673-1677.
5. Friedenstein A., Chailakhjan R., Lalykina K. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif. 1970, 3:393-403.
6. Hoch A.I., Leach J.K. Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl. Med. 2014, 2013-2196.
7. English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol. Cell Biol. 2013, 91:19-26.
8. Mendicino M., Bailey A.M., Wonnacott K., Puri R.K., Bauer S.R. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 2014, 14:141-145.
9. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., Sussman M., Orchard P., Marx J.C., Pyeritz R.E. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
10. Yin F., Battiwalla M., Ito S., Feng X., Chinian F., Melenhorst J.J., Koklanaris E., Sabatino M., Stroncek D., Samsel L. Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses. Stem Cells 2014, 32:1278-1288.
11. Galipeau J. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy 2013, 15:2-8.
12. von Bahr L., Sundberg B., Lönnies L., Sander B., Karbach H., Hägglund H., Ljungman P., Gustafsson B., Karlsson H., Le Blanc K. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol. Blood Marrow Transplant. 2012, 18:557-564.
13. Hupfeld J., Gorr I.H., Schwald C., Beaucamp N., Wiechmann K., Kuentzer K., Huss R., Rieger B., Neubauer M., Wegmeyer H. Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors. Biotechnol. Bioeng. 2014, 111:2290-2302.
14. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
15. Kuznetsov S.A., Mankani M.H., Bianco P., Robey P.G. Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res. 2009, 2:83-94.
16. Russell K.C., Lacey M.R., Gilliam J.K., Tucker H.A., Phinney D.G., O'Connor K.C. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol. Bioeng. 2011, 108:2716-2726.
17. Zhang S., Ge J., Sun A., Xu D., Qian J., Lin J., Zhao Y., Hu H., Li Y., Wang K. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J. Cell. Biochem. 2006, 99:1132-1147.
18. Lee R.H., Hsu S.C., Munoz J., Jung J.S., Lee N.R., Pochampally R., Prockop D.J. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006, 107:2153-2161.
19. Russell K.C., Phinney D.G., Lacey M.R., Barrilleaux B.L., Meyertholen K.E., O'Connor K.C. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010, 28:788-798.
20. Larson B.L., Ylöstalo J., Prockop D.J. Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells 2008, 26:193-201.
21. Ho J.H., Chen Y.-F., Ma W.-H., Tseng T.-C., Chen M.-H., Lee O.K. Cell contact accelerates replicative senescence of human mesenchymal stem cells independent of telomere shortening and p53 activation: roles of Ras and oxidative stress. Cell Transplant. 2011, 20:1209-1220.
22. Grayson W.L., Zhao F., Bunnell B., Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2007, 358:948-953.
23. Gharibi B., Farzadi S., Ghuman M., Hughes F.J. Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells. Stem Cells 2014, 32:2256-2266.
24. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 2004, 6:483-495.
25. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
26. Ruiz S.A., Chen C.S. Emergence of patterned stem cell differentiation within multicellular structures. Stem Cells 2008, 26:2921-2927.
27. Lee J., Abdeen A.A., Kim A.S., Kilian K.A. The influence of biophysical parameters on maintaining the mesenchymal stem cell phenotype. ACS Biomater. Sci. Eng. 2015.
28. Abdeen A.A., Weiss J.B., Lee J., Kilian K.A. Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells. Tissue Eng. A 2014, 20:2737-2745.
29. Seib F.P., Prewitz M., Werner C., Bornhäuser M. Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs). Biochem. Biophys. Res. Commun. 2009, 389:663-667.
30. Stenekes R.J., De Smedt S.C., Demeester J., Sun G., Zhang Z., Hennink W.E. Pore sizes in hydrated dextran microspheres. Biomacromolecules 2000, 1:696-703.
31. Abraham Cohn N., Kim B.-S., Erkamp R.Q., Mooney D.J., Emelianov S.Y., Skovoroda A.R., O'Donnell M. High-resolution elasticity imaging for tissue engineering. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2000, 47:956-966.
32. McMurray R.J., Gadegaard N., Tsimbouri P.M., Burgess K.V., McNamara L.E., Tare R., Murawski K., Kingham E., Oreffo R.O., Dalby M.J. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat. Mater. 2011, 10:637-644.
33. Yang C., Tibbitt M.W., Basta L., Anseth K.S. Mechanical memory and dosing influence stem cell fate. Nat. Mater. 2014, 13:645-652.
34. Barrett P.N., Mundt W., Kistner O., Howard M.K. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev. Vaccines 2009, 8:607-618.
35. Glossop J.R., Cartmell S.H. Effect of fluid flow-induced shear stress on human mesenchymal stem cells: differential gene expression of IL1B and MAP3K8 in MAPK signaling. Genes Expr. Pattern 2009, 9:381-388.
36. Zhao F., Chella R., Ma T. Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: experiments and hydrodynamic modeling. Biotechnol. Bioeng. 2007, 96:584-595.
37. Kreke M.R., Goldstein A.S. Hydrodynamic shear stimulates osteocalcin expression but not proliferation of bone marrow stromal cells. Tissue Eng. 2004, 10:780-788.
38. Chen X.D., Dusevich V., Feng J.Q., Manolagas S.C., Jilka R.L. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J. Bone Miner. Res. 2007, 22:1943-1956.
39. Kim J., Ma T. Regulation of autocrine fibroblast growth factor-2 signaling by perfusion flow in 3D human mesenchymal stem cell constructs. Biotechnol. Progr. 2012, 28:1384-1388.
40. Tamura A., Kobayashi J., Yamato M., Okano T. Thermally responsive microcarriers with optimal poly (N-isopropylacrylamide) grafted density for facilitating cell adhesion/detachment in suspension culture. Acta Biomater. 2012, 8:3904-3913.
41. Skardal A., Sarker S.F., Crabbé A., Nickerson C.A., Prestwich G.D. The generation of 3-D tissue models based on hyaluronan hydrogel-coated microcarriers within a rotating wall vessel bioreactor. Biomaterials 2010, 31:8426-8435.
42. Nienow A.W., Rafiq Q.A., Coopman K., Hewitt C.J. A potentially scalable method for the harvesting of hMSCs from microcarriers. Biochem. Eng. J. 2014, 85:79-88.
43. Sart S., Agathos S.N., Li Y. Engineering stem cell fate with biochemical and biomechanical properties of microcarriers. Biotechnol. Prog. 2013, 29:1354-1366.
44. Meuwly F., Ruffieux P.-A., Kadouri A., Von Stockar U. Packed-bed bioreactors for mammalian cell culture: bioprocess and biomedical applications. Biotechnol. Adv. 2007, 25:45-56.
45. Liu Y., Ma T. Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application. Biotechnol. Prog. 2015, 31:468-481.
46. Sart S., Ma T., Li Y. Preconditioning stem cells for in vivo delivery. Biores. Open Access 2014, 3:137-149.
47. Heathman T.R., Glyn V.A., Picken A., Rafiq Q.A., Coopman K., Nienow A.W., Kara B., Hewitt C.J. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol. Bioeng. 2015, 112:1696-1707.
48. Cunha B., Aguiar T., Silva M.M., Silva R.J., Sousa M.F., Pineda E., Peixoto C., Carrondo M.J., Serra M., Alves P.M. Exploring continuous and integrated strategies for the up- and downstream processing of human mesenchymal stem cells. J. Biotechnol. 2015, 10.1016/j.jbiotec.2015.02.023.
49. Samsonraj R.M., Rai B., Sathiyanathan P., Puan K.J., Rotzschke O., Hui J.H., Raghunath M., Stanton L.W., Nurcombe V., Cool S.M. Establishing criteria for human mesenchymal stem cell potency. Stem Cells 2015, 33:1878-1891.
50. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp. Hematol. 2000, 28:707-715.
51. Halfon S., Abramov N., Grinblat B., Ginis I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2010, 20:53-66.
52. Schellenberg A., Stiehl T., Horn P., Joussen S., Pallua N., Ho A.D., Wagner W. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy 2012, 14:401-411.
53. Redaelli S., Bentivegna A., Foudah D., Miloso M., Redondo J., Riva G., Baronchelli S., Dalprà L., Tredici G. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res. Ther. 2012, 3:47.
54. Whitfield M.J., Lee W.C.J., Van Vliet K.J. Onset of heterogeneity in culture-expanded bone marrow stromal cells. Stem Cell Res. 2013, 11:1365-1377.
55. Braccini A., Wendt D., Farhadi J., Schaeren S., Heberer M., Martin I. The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells. J. Tissue Eng. Regen. Med. 2007, 1:60-65.
56. Bork S., Pfister S., Witt H., Horn P., Korn B., Ho A.D., Wagner W. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010, 9:54-63.
57. Yoon Y.S., Wecker A., Heyd L., Park J.-S., Tkebuchava T., Kusano K., Hanley A., Scadova H., Qin G., Cha D.-H. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 2005, 115:326.
58. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P.G., Riminucci M. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
59. Lee R.H., Seo M.J., Pulin A.A., Gregory C.A., Ylostalo J., Prockop D.J. The CD34-like protein PODXL and α6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 2009, 113:816-826.
60. Lee R.H., Hsu S.C., Munoz J., Jung J.S., Lee N.R., Pochampally R., Prockop D.J. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006, 107:2153-2161.
61. Lee M.W., Kim D.S., Ryu S., Jang I.K., Kim H.J., Yang J.M., Lee D.-H., Lee S.H., Son M.H., Cheuh H.W. Effect of ex vivo culture conditions on immunosuppression by human mesenchymal stem cells. Biomed. Res. Int. 2013, 2013.
62. Russell K.C., Tucker H.A., Bunnell B.A., Andreeff M., Schober W., Gaynor A.S., Strickler K.L., Lin S., Lacey M.R., O'Connor K.C. Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells. Tissue Eng. A 2013, 19:2253-2266.
63. Boregowda S.V., Krishnappa V., Chambers J.W., Lograsso P.V., Lai W.T., Ortiz L.A., Phinney D.G. Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells 2012, 30:975-987.
64. Carlos Sepúlveda J., Tomé M., Eugenia Fernández M., Delgado M., Campisi J., Bernad A., González M.A. Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. Stem Cells 2014, 32:1865-1877.